Table 6 Drugs Commonly Tested Using Patch Tests
| Â | Europe, n (%) | Asia Pacific, n (%) | North America, n (%) | Latin America, n (%) | Africa Middle East, n (%) | Region Not Specified, n (%) | Total (n = 48), n (%) |
|---|---|---|---|---|---|---|---|
Antibiotics (beta-lactams) | 22 (45.8) | 6 (12.5) | 4 (8.3) | 6 (12.5) | 3 (6.3) | 1 (2.1) | 40 (83.3) |
Antibiotics (non-beta-lactams) | 19 (39.6) | 1 (2.1) | 4 (8.3) | 5 (10.4) | 2 (4.2) | 0 (0.0) | 31 (64.6) |
Corticosteroids | 20 (41.7) | 3 (6.3) | 2 (4.2) | 3 (6.3) | 1 (2.1) | 0 (0.0) | 29 (60.4) |
Anti-epileptics | 19 (39.6) | 1 (2.1) | 2 (4.2) | 5 (10.4) | 0 (0.0) | 1 (2.1) | 28 (58.3) |
Cotrimoxazole | 16 (33.3) | 1 (2.1) | 2 (4.2) | 3 (6.3) | 0 (0.0) | 0 (0.0) | 22 (45.8) |
NSAIDs and Selective Cox-2 inhibitors | 13 (27.1) | 3 (6.3) | 2 (4.2) | 3 (6.3) | 1 (2.1) | 1 (2.1) | 21 (43.8) |
Anti-tuberculous drugs | 12 (25.0) | 1 (2.1) | 1 (2.1) | 2 (4.2) | 0 (0.0) | 1 (2.1) | 17 (35.4) |
Radiocontrast media | 13 (27.1) | 1 (2.1) | 1 (2.1) | 1 (2.1) | 0 (0.0) | 0 (0.0) | 16 (33.3) |
Acyclovir | 11 (22.9) | 0 (0.0) | 1 (2.1) | 2 (4.2) | 0 (0.0) | 0 (0.0) | 14 (29.2) |